Keisuke Taniuchi, President and Representative Director of our company, made a presentation on “Evaluation of Drug Efficacy of Sirolimus in Combination with Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer” at the mini-symposium of the 55th Congress of the Japanese Pancreatic Association held in Utsunomiya, Japan, on July 25-26, 2024. Drug efficacy evaluation experiments were conducted using mice transplanted with human pancreatic cancer organoids.